⾎液内科教室業績（2008 年 1 ⽉から 2018 年 5 ⽉まで、
peer review を要する英⽂論⽂に限る）(1-68)
1.

Takami A. Hematopoietic stem cell transplantation for acute myeloid leukemia. Int J

Hematol. 2018;107(5):513-8.
2.

Kurahashi H, Takami A, Murotani K, Numoto S, Okumura A. Decreased platelet countin children with epilepsy treated with valproate and its relationship to the immature platelet
fraction. Int J Hematol. 2018;107(1):105-11.
3.

Iida S, Wakabayashi M, Tsukasaki K, Miyamoto K, Maruyama D, Yamamoto K,

Takatsuka Y, Kusumoto S, Kuroda J, Ando K, Kikukawa Y, Masaki Y, Kobayashi M, Hanamura I,
Asai H, Nagai H, Shimada K, Tsukamoto N, Inoue Y, Tobinai K. Bortezomib plus dexamethasone
vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma. Cancer Sci. 2018.
4.

Yisireyili M, Hayashi M, Wu H, Uchida Y, Yamamoto K, Kikuchi R, Shoaib Hamrah M,

Nakayama T, Wu Cheng X, Matsushita T, Nakamura S, Niwa T, Murohara T, Takeshita K.
Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose
dysmetabolism, and prothrombotic state in mice. Sci Rep. 2017;7(1):1266.
5.

Yanada M, Yano S, Kanamori H, Gotoh M, Emi N, Watakabe K, Kurokawa M, Nishikawa

A, Mori T, Tomita N, Murata M, Hashimoto H, Henzan H, Kanda Y, Sawa M, Kohno A, Atsuta Y,
Ichinohe T, Takami A. Autologous hematopoietic cell transplantation for acute promyelocytic
leukemia in second complete remission: outcomes before and after the introduction of arsenic
trioxide. Leuk Lymphoma. 2017;58(5):1061-7.
6.

Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I,

Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K,
Mori T, Ogawa S, Takami A. Toll-like receptor genetic variations in bone marrow transplantation.
Oncotarget. 2017;8(28):45670-86.
7.

Takami A, Goto M, Watarai M, Uchino K, Yamamoto H, Gotou M, Mizuno S, Takahashi

M, Horio T, Nakamura A, Takasugi S, Nakayama T, Hanamura I, Imamura A, Mihara H, Enomoto
M. A Higher Immature Platelet Fraction Predicts a Response to Corticosteroids in Adult Patientswith

ImmuneThrombocytopenia.

International

JournalofLaboratory

Hematology.

2017;39(Supplement S2):116-.
8.

Nakayama T, Mizutani K, Hanamura I, Kato H, Takami A, Takeshita K, Watanabe D.

Livedoid vasculopathy and popliteal artery occlusion in a patient with protein S deficiency. J
Dermatol. 2017;44(2):198-201.

1

9.

Nakane T, Nakamae H, Yamaguchi T, Kurosawa S, Okamura A, Hidaka M, Fuji S, Kohno

A, Saito T, Aoyama Y, Hatanaka K, Katayama Y, Yakushijin K, Matsui T, Yamamori M, Takami A,
Hino M, Fukuda T. Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic
hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer
donors: Japanese multicenter phase II trials. Int J Hematol. 2017;105(4):485-96.
10.

Nakagami Y, Kishi T, Tani H, Wakabayashi H, Kasugai K, Okumura A, Takami A.

Peripheral Blood Smear Tells: An Appraisal of the Howell-Jolly Bodies. International Journal ofLaboratory Hematology. 2017;39(Supplement S2):83-.
11.

Mizutani M, Takami A, Hara M, Mizuno S, Yanada M, Chou T, Uchiyama H, Ohashi K,

Miyamoto T, Ozawa Y, Imataki O, Kobayashi N, Uchida N, Kanamori H, Kamimura T, Eto T,
Onizuka M, Tanaka J, Atsuta Y, Yano S. Comparison of Autologous and Unrelated Transplants
for Cytogenetically Normal Acute Myelogenous Leukemia. Biol Blood Marrow Transplant.
2017;23(9):1447-54.
12.

Konuma T, Kondo T, Yamashita T, Uchida N, Fukuda T, Ozawa Y, Ohashi K, Ogawa H,

Kato C, Takahashi S, Kanamori H, Eto T, Nakaseko C, Kohno A, Ichinohe T, Atsuta Y, Takami A,
Yano S, Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic
Cell T. Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute
myeloid leukemia harboring trisomy 8. Ann Hematol. 2017;96(3):469-78.
13.

Kasagi T, Nobata H, Suzuki K, Miura N, Banno S, Takami A, Yamashita T, Ando Y, Imai

H. Light Chain Deposition Disease Diagnosed with Laser Micro-dissection, Liquid
Chromatography, and Tandem Mass Spectrometry of Nodular Glomerular Lesions. Intern Med.
2017;56(1):61-6.
14.

Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M,

Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A. The
recipient CCR5 variation predicts survival outcomes after bone marrow transplantation. Transpl
Immunol. 2017;42:34-9.
15.

Hanamura I, Ota A, Karnan S, Wahiduzzaman M, Mizuno S, Uchino K, Kanasugi J,

Horio T, Murakami S, Suzuki S, Ueda R, Tsuzuki S, Konishi H, Hosokawa Y, Takami A. SingleNucleotide Polymorphism in the Pbk Gene Is Closely Associated with Myeloma Cell Proliferation.
Haematologica. 2017;102(s2):497-.
16.

Espinoza JL, Trung LQ, Inaoka PT, Yamada K, An DT, Mizuno S, Nakao S, Takami A.

The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell
Subsets in Humans. Oxid Med Cell Longev. 2017;2017:6781872.
17.

Espinoza JL, Elbadry MI, Taniwaki M, Harada K, Trung LQ, Nakagawa N, Takami A,

Ishiyama K, Yamauchi T, Takenaka K, Nakao S. The simultaneous inhibition of the mTOR and
MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia. Cancer Lett.

2

2017;400:127-36.
18.

Yisireyili M, Takeshita K, Hayashi M, Wu H, Uchida Y, Yamamoto K, Kikuchi R, Hao

CN, Nakayama T, Cheng XW, Matsushita T, Nakamura S, Murohara T. Dipeptidyl peptidase- IV
inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine
model. Psychoneuroendocrinology. 2016;73:186-95.
19.

Ozaki S, Hata H, Abe M, Saitoh T, Hanamura I, Yano H, Sunami K, Kosugi H, Sawamura

M, Nakazato T, Masunari T, Mori M, Takagi T, Murakami H, Shimizu K. Reduced frequency
treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or
refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902).
Ann Hematol. 2016;95(6):921-9.
20.

Oyake T, Fujisawa Y, Sugawara N, Sasaki R, Izumita W, Mine T, Asahi M, Suzuki Y,

Okano Y, Fujishima Y, Tsukushi Y, Aoki Y, Kowata S, Hanamura I, Murai K, Ito S, Ishida Y.
Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy inFebrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial.
Blood. 2016;128(22):1607-.
21.

Nomoto H, Takami A, Espinoza JL, Matsuo K, Mizuno S, Onizuka M, Kashiwase K,

Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Nakao S, Ohtake S, Morishita
E. Erratum to: A donor thrombomodulin gene variation predicts graft-versus-host diseasedevelopment and mortality after bone marrow transplantation. Int J Hematol. 2015;102(4):507-8.
22.

Kawano N, Kuriyama T, Yoshida S, Shimizu I, Kobayashi H, Takenaka K, Uchida N,

Takami A, Yamashita K, Ueda A, Kikuchi I. Successful Secondary Umbilical Cord Blood
Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified OneDay Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of
Mycophenolate and Tacrolimus. J Clin Exp Hematop. 2015;55(2):89-96.
23.

Kato H, Nakayama T, Uruma M, Okuyama Y, Handa M, Tomiyama Y, Shimodaira S,

Takamoto S. Repeated exposure rather than the total volume of transfused components may
influence the incidence of allergic transfusion reactions. Transfusion. 2015;55(11):2576-81.
24.

Kato H, Nakayama T, Uruma M, Okuyama Y, Handa M, Tomiyama Y, Shimodaira S,

Takamoto S. A retrospective observational study to assess adverse transfusion reactions of patientswith and without prior transfusion history. Vox sanguinis. 2015;108(3):243-50.
25.

Mochizuki K, Kondo Y, Hosokawa K, Ohata K, Yamazaki H, Takami A, Sasaki M, Sato

Y, Nakanuma Y, Nakao S. Adenovirus pneumonia presenting with nodular shadows on chest Xray in two unrelated allogeneic bone marrow transplant recipients. Intern Med. 2014;53(5):499503.
26.

Goto M, Miwa H, Suganuma K, Tsunekawa-Imai N, Shikami M, Mizutani M, Mizuno S,

Hanamura I, Nitta M. Adaptation of leukemia cells to hypoxic condition through switching the3

energy metabolism or avoiding the oxidative stress. BMC Cancer. 2014;14:76.
27.

Goto M, Miwa H, Shikami M, Tsunekawa-Imai N, Suganuma K, Mizuno S, Takahashi

M, Mizutani M, Hanamura I, Nitta M. Importance of glutamine metabolism in leukemia cells byenergy production through TCA cycle and by redox homeostasis. Cancer Invest. 2014;32(6):2417.
28.

Tsunekawa-Imai N, Miwa H, Shikami M, Suganuma K, Goto M, Mizuno S, Takahashi

M, Mizutani M, Horio T, Komatsubara H, Gotou M, Yamamoto H, Wakabayashi M, Watarai M,
Hanamura I, Imamura A, Mihara H, Nitta M. Growth of xenotransplanted leukemia cells is
influenced by diet nutrients and is attenuated with 2-deoxyglucose. Leuk Res. 2013;37(9):1132-6.
29.

Takami A, Espinoza JL, Trung LQ, Nakao S. The cellular mechanism underlying theanti-leukemia effects of resveratrol. Resveratrol 2013 Regional Meeting. 2013.
30.

Takahashi M, Ota A, Karnan S, Hossain E, Konishi Y, Damdindorj L, Konishi H, Yokochi

T, Nitta M, Hosokawa Y. Arsenic trioxide prevents nitric oxide production in lipopolysaccharide stimulated RAW 264.7 by inhibiting a TRIF-dependent pathway. Cancer Sci. 2013;104(2):165-70.
31.

Miwa H, Shikami M, Goto M, Mizuno S, Takahashi M, Tsunekawa-Imai N, Ishikawa T,

Mizutani M, Horio T, Gotou M, Yamamoto H, Wakabayashi M, Watarai M, Hanamura I, Imamura
A, Mihara H, Nitta M. Leukemia cells demonstrate a different metabolic perturbation provokedby 2-deoxyglucose. Oncol Rep. 2013;29(5):2053-7.
32.

Inagaki A, Tajima E, Uranishi M, Totani H, Asao Y, Ogura H, Masaki A, Yoshida T,

Mori F, Ito A, Yano H, Ri M, Kayukawa S, Kataoka T, Kusumoto S, Ishida T, Hayami Y, Hanamura
I, Komatsu H, Inagaki H, Matsuda Y, Ueda R, Iida S. Global real-time quantitative reverse
transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32
chromosomal translocation as a valuable marker for predicting survival in multiple myeloma. LeukRes. 2013;37(12):1648-55.
33.

Hossain E, Ota A, Takahashi M, Karnan S, Damdindorj L, Konishi Y, Konishi H,

Hosokawa Y. Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic
endothelial cells. Toxicol Lett. 2013;220(1):70-5.
34.

Hossain E, Ota A, Karnan S, Damdindorj L, Takahashi M, Konishi Y, Konishi H,

Hosokawa Y. Arsenic augments the uptake of oxidized LDL by upregulating the expression oflectin-like oxidized LDL receptor in mouse aortic endothelial cells. Toxicol Appl Pharmacol.
2013;273(3):651-8.
35.

Yamashita T, Fukuda T, Taniguchi S, Ohashi K, Kurosawa S, Morishima Y, Nagamura

T, Sakamaki H, Atsuta Y, Takami A. Intravenous Busulfan-Based Myeloablative Conditioning Is
Comparable to TBI-Based Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for
Recipients with Acute Myeloid Leukemia: A Nationwide Retrospective Study From the Adult
Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell

4

Transplantation. ASH Annual Meeting Abstracts. 2012;120(21):1922-.
36.

Trung LQ, Espinoza LJ, Takami A, Yoshida A, Nakao S. Resveratrol Induces Cell Cycle

Arrest and Apoptosis in Malignant NK Cells Via JAK2/STAT3 Pathway Inhibition. ASH Annual
Meeting Abstracts. 2012;120(21):1343-.
37.

Takami A, Espinoza JL, Matsuo K, Morishima Y, Onizuka M, Kashiwase K, Fukuda T,

Kodera Y, Nakao S. Association of Functional Single Nucleotide Variation in the NLRP3 Genewith Survival Outcomes After Unrelated Bone Marrow Transplantation. ASH Annual Meeting
Abstracts. 2012;120(21):3140-.
38.

Nagoshi H, Taki T, Hanamura I, Nitta M, Otsuki T, Nishida K, Okuda K, Sakamoto N,

Kobayashi S, Yamamoto-Sugitani M, Tsutsumi Y, Kobayashi T, Matsumoto Y, Horiike S, Kuroda
J, Taniwaki M. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1WWOX occur in multiple myeloma with 8q24 abnormality. Cancer research. 2012;72(19):495462.
39.

Konishi Y, Karnan S, Takahashi M, Ota A, Damdindorj L, Hosokawa Y, Konishi H. A

system for the measurement of gene targeting efficiency in human cell lines using an antibiotic
resistance-GFP fusion gene. BioTechniques. 2012;53(3):141-52.
40.

Karnan S, Konishi Y, Ota A, Takahashi M, Damdindorj L, Hosokawa Y, Konishi H.

Simple monitoring of gene targeting efficiency in human somatic cell lines using the PIGA gene.
PLoS One. 2012;7(10):e47389.
41.

Kanamori H, Fukuda T, Taniguchi S, Sawa M, Kondo T, Miyamura K, Kobayashi N,

Kobayashi H, Morishima Y, Hirokawa M, Atsuta Y, Takami A. Outcome and Prognostic Index for
Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST) for Elderly Patients with De
Novo Acute Myeloid Leukemia (AML): A Study From the AML Working Group of the Japan
Society for Hematopoietic Cell Transplantation (JSHCT). ASH Annual Meeting Abstracts.
2012;120(21):1918-.
42.

Hatanaka K, Fuji S, Ikegame K, Kato R, Wake A, Hidaka M, Ito T, Inoue M, Nagatoshi

Y, Takami A, Uike N, Sakamaki H, Yabe H, Morishima Y, Suzuki R, Atsuta Y, Fukuda T. Erratum
to: Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrowtransplantation with low-dose anti-T lymphocyte globulin. International Journal of Hematology.
2012;97(1):154-5.
43.

Gotou M, Hanamura I, Nagoshi H, Wakabayashi M, Sakamoto N, Tsunekawa N, Horio

T, Goto M, Mizuno S, Takahashi M, Suganuma K, Yamamoto H, Hiramatsu A, Watarai M,
Shikami M, Imamura A, Mihara H, Taki T, Miwa H, Taniwaki M, Nitta M. Establishment of anovel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without
chimeric MN1-TEL and with high expression of MN1. Genes Chromosomes Cancer.
2012;51(1):42-53.

5

44.

Damdindorj L, Karnan S, Ota A, Takahashi M, Konishi Y, Hossain E, Hosokawa Y,

Konishi H. Assessment of the long-term transcriptional activity of a 550-bp-long human beta-actin
promoter region. Plasmid. 2012;68(3):195-200.
45.

Yano S, Yokoyama H, Nishimura R, Fukuda T, Ogawa H, Ohashi K, Kanamori H, Tanaka

J, Sakamaki H, Atsuta Y, Takami A. Prognostic Factors of Reducing Relapse in Patients
Undergoing Allogeneic Hematopoietic Cell Transplantation From Related Donor for Acute
Myeloid Leukemia: The Japan Society for Hematopoietic Cell Transplantation (JSHCT) AML
Working Group. ASH Annual Meeting Abstracts. 2011;118(21):3085-.
46.

Shaughnessy JD, Jr., Qu P, Usmani S, Heuck CJ, Zhang Q, Zhou Y, Tian E, HanamuraI, van Rhee F, Anaissie E, Epstein J, Nair B, Stephens O, Williams R, Waheed S, Alsayed Y, Crowley
J, Barlogie B. Pharmacogenomics of bortezomib test-dosing identifies hyperexpression ofproteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total
Therapy 3. Blood. 2011;118(13):3512-24.
47.

Nakata K, Espinoza JL, Onizuka M, Fukuda T, Kawase T, Morishita E, Kodera Y,

Morishima Y, Ohtake S, Nakao S, Takami A. The Association of a Single Nucleotide
Polymorphism in the Chemokine CXCL10 Gene with Transplant Outcomes After HLA-Matched
Unrelated Bone Marrow Transplantation for Low Risk Hematologic Malignancies. ASH Annual
Meeting Abstracts. 2011;118(21):2048-.
48.

Kimura Y, Ding B, Imai N, Nolan DJ, Butler JM, Rafii S. c-Kit-mediated functional

positioning of stem cells to their niches is essential for maintenance and regeneration of adulthematopoiesis. PLoS One. 2011;6(10):e26918.
49.

Yamamoto H, Nishimaki H, Imai N, Nitta M, Daimaru O. Aortic thrombus in a patientwith myeloproliferative thrombocytosis, successfully treated by pharmaceutical therapy: a casereport. Journal of medical case reports. 2010;4:219.
50.

Suganuma K, Miwa H, Imai N, Shikami M, Gotou M, Goto M, Mizuno S, Takahashi M,

Yamamoto H, Hiramatsu A, Wakabayashi M, Watarai M, Hanamura I, Imamura A, Mihara H,
Nitta M. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation. Leuk
Lymphoma. 2010;51(11):2112-9.
51.

Espinoza LJ, Takami A, Yoshioka K, Nakata K, Nakao S. A Functional Variation In the

NKG2D Gene Regulates NKG2D Receptor Expression and Is Associated with Better Transplant
Outcomes After Fully-HLA-Matched Unrelated Bone Marrow Transplantation. ASH Annual
Meeting Abstracts. 2010;116(21):221-.
52.

Espinoza JL, Takami A, Yoshioka K, Sato H, Nakao S. A functional polymorphism in the

3' untranslated region of the NKG2D gene regulates NKG2D receptor expression. Jpn J Clin
Hematol. 2010;51(9):291a.
53.

Espinoza JL, Takami A, Yoshioka K, Nakata K, Nakao S. A Functional Variation In the6

NKG2D Gene Regulates NKG2D Receptor Expression and Is Associated with Better Transplant
Outcomes After Fully-HLA-Matched Unrelated Bone Marrow Transplantation. ASH Annual
Meeting Abstracts. 2010;116(21):221-.
54.

Espinoza JL, Takami A, Nakata K, Kato S, Kasahara Y, Nakao S. Resveratrol, a Natural

Antioxidant From Grapes and Red Wines, Prevents EBV-Associated Lymphoproliferation andTransformation

through

Inducing

Apoptosis.

ASH

AnnualMeeting

Abstracts.

2010;116(21):2543-.
55.

Asakura M, Ikegame K, Yoshihara S, Taniguchi S, Mori T, Etoh T, Takami A, Yoshida

T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. Useof foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationfrom a related donor. Int J Hematol. 2010;92(2):351-9.
56.

Yamashita T, Sugimori C, Ishiyama K, Yamazaki H, Okumura H, Kondo Y, Takami A,

Nakao S. Cord blood transplantation using minimum conditioning regimens for patients withhematologic malignancies complicated by severe infections. Int J Hematol. 2009;89(2):238-42.
57.

Takami A, Espinoza JL, Onizuka M, Kawase T, Katagiri T, Ohtake S, Morishima Y,

Fukuda T, Kodera Y, Nakao S. Significant Impact of IL-17A Gene Polymorphism On Transplant
Outcomes After HLA-Fully-Matched Unrelated Bone Marrow Transplantation. ASH Annual
Meeting Abstracts. 2009;114(22):2305-.
58.

Sugimori N, Kondo Y, Shibayama M, Omote M, Takami A, Sugimori C, Ishiyama K,

Yamazaki H, Nakao S. Aberrant increase in the immature platelet fraction in patients withmyelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis.
European journal of haematology. 2009;82(1):54-60.
59.

Sugimori C, Mochizuki K, Qi Z, Sugimori N, Ishiyama K, Kondo Y, Yamazaki H, Takami

A, Okumura H, Nakao S. Origin and fate of blood cells deficient in glycosylphosphatidylinositolanchored protein among patients with bone marrow failure. Br J Haematol. 2009;147(1):102-12.
60.

Ishiyama K, Takami A, Suzuki S, Konaka H, Namiki M, Ooi A, Nakao S. Relationshipbetween tumor-infiltrating T lymphocytes and clinical response after reduced-intensity allogeneic
hematopoietic stem cell transplantation for advanced renal cell carcinoma: a single centerprospective study. Jpn J Clin Oncol. 2009;39(12):807-12.
61.

Imai N, Miwa H, Shikami M, Suganuma K, Gotoh M, Hiramatsu A, Wakabayashi M,

Watarai M, Hanamura I, Imamura A, Mihara H, Shitara K, Shibuya M, Nitta M. Growth inhibitionof AML cells with specific chromosome abnormalities by monoclonal antibodies to receptors for
vascular endothelial growth factor. Leuk Res. 2009;33(12):1650-7.
62.

Espinoza JL, Takami A, Onizuka M, Sao H, Akiyama H, Miyamura K, Okamoto S, Inoue

M, Kanda Y, Ohtake S, Fukuda T, Morishima Y, Kodera Y, Nakao S, Japan Marrow Donor P.
NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-

7matched unrelated bone marrow transplantation for standard risk hematologic malignancies.
Haematologica. 2009;94(10):1427-34.
63.

Yamamoto H, Kato H, Uruma M, Nitta M, Takamoto S. Identification of two distinct

populations of endothelial progenitor cells differing in size and antigen expression from humanumbilical cord blood. Ann Hematol. 2008;87(2):87-95.
64.

Takamatsu H, Yamazaki H, Yamashita T, Takami A, Okumura H, Nakao S. A marked

increase in myeloblasts in the peripheral blood of a patient with Burkitt lymphoma following
granulocyte colony-stimulating factor administration. Acta Haematol. 2008;120(3):174-6.
65.

Mochizuki K, Sugimori C, Qi Z, Lu X, Takami A, Ishiyama K, Kondo Y, Yamazaki H,

Okumura H, Nakao S. Expansion of donor-derived hematopoietic stem cells with PIGA mutation
associated with late graft failure after allogeneic stem cell transplantation. Blood.
2008;112(5):2160-2.
66.

Lu X, Kondo Y, Takamatsu H, Ohata K, Yamazaki H, Takami A, Akatsuka Y, Nakao S.

CD16+ CD56- NK cells in the peripheral blood of cord blood transplant recipients: a uniquesubset of NK cells possibly associated with graft-versus-leukemia effect. European journal of
haematology. 2008;81(1):18-25.
67.

Ishizaki J, Ito S, Jin M, Shimada T, Ishigaki T, Harasawa Y, Yokogawa K, Takami A,

Nakao S, Miyamoto K. Mechanism of decrease of oral bioavailability of cyclosporin A during
immunotherapy

uponcoadministrationofamphotericin

B.

Biopharm

Drug

Dispos.

2008;29(4):195-203.
68.

Hayashi T, Morishita E, Ohtake H, Oda Y, Ohta K, Arahata M, Kadohira Y, Maekawa M,

Ontachi Y, Yamazaki M, Asakura H, Takami A, Nakao S. Expression of annexin II in humanatherosclerotic abdominal aortic aneurysms. Thromb Res. 2008;123(2):274-80.

8